Search clinical trials for: LAS 41002

Total 1952 results

Almirall, S.A.

Completed

Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

Atopic Eczema

Germany
Almirall, S.A.

Completed

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Psoriasis

Germany
Almirall, S.A.

Completed

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Psoriasis

Germany
Peking University Third Hospital

Completed

Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

China
Ewha Womans University

Completed

Comparison of Nonposterior- and Posterior-Stabilized Mobile-Bearing Total Knee Arthroplasty

Osteoarthritis

Korea, Republic of
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
Capricor Inc.

Completed

Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) (HOPE-OLE)

Duchenne Muscular Dystrophy

United States
Capricor Inc.

Completed

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (HOPE)

Duchenne Muscular Dystrophy | Cardiomyopathy

United States
HK inno.N Corporation

Completed

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects (hGH)

Healthy
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

China
Neurological Associates of West Los Angeles

Enrolling by invitation

Focused Ultrasound for the Treatment of ADHD Symptoms

ADHD

United States
Quark Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Acute Kidney Injury

United States, Canada, Germany
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects

Healthy

United States
Quark Pharmaceuticals

Terminated

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Cardiac Surgery

United States, Germany, Spain, Australia, Austria, Canada, New Zealand, United Kingdom, Belgium, Czechia, France
Quark Pharmaceuticals

Completed

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation

Delayed Graft Function | Other Complication of Kidney Transplant

United States, Spain, Germany, France, Canada
Quark Pharmaceuticals

Terminated

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

Acute Kidney Injury | Acute Renal Failure

United States
Quark Pharmaceuticals

Completed

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant (ReGIFT)

Delayed Graft Function

United States, Spain, Canada, Australia, Netherlands, Germany, Belgium, France, Argentina, Brazil, Czechia
Massachusetts General Hospital

Active, not recruiting

Neuromodulation of Mind-Wandering in Depression

Depression

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
Massachusetts General Hospital

Withdrawn

Focused Ultrasound Neuromodulation for Treatment of Temporal Lobe Epilepsy (LIFUP)

Low Intensity Ultrasound Pulsarions
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects

Healthy

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects

Antineutrophil Cytoplasmic Antibody Associated Vasculitis

United States
Asklepios Biopharmaceutical, Inc.

Recruiting

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure (GenePHIT)

Congestive Heart Failure

United States
National Institute of Environmental Health Sciences...
National Center for Research Resources (NCRR)

Completed

The Genetics of Environmental Asthma

Asthma

United States
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Terminated

A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Healthy Subject

China
Capricor Inc.

Active, not recruiting

Open-label Extension of the HOPE-2 Trial (HOPE-2-OLE)

Duchenne Muscular Dystrophy

United States
Capricor Inc.

No longer available

CAP-1002 in Severe COVID-19 Disease

COVID-19

United States
Oregon Health and Science University
University of Oregon; Oregon State University

Recruiting

Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance

Carbohydrate Intolerance

United States
Cutia Therapeutics（Wuxi）Co.,Ltd

Completed

A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

AGA

China
Capricor Inc.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Unknown

Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) (DYNAMIC)

Heart Failure | Ischemic Cardiomyopathy | Nonischemic Cardiomyopathy | Dilated Cardiomyopathy (DCM)

United States
Esperion Therapeutics, Inc.

Completed

A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance

Hypercholesterolemia

United States
Saol Therapeutics Inc

Active, not recruiting

Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity (RAISE)

Spasticity

United States
OliPass Corporation
Novotech (Australia) Pty Limited

Completed

Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint

Osteoarthritis

Australia
David Brienza

Completed

An RCT on Support Surfaces for Pressure Ulcer Prevention

Pressure Ulcer | Pressure Injury

United States
Hospital Universitari de Bellvitge

Completed

Lumen Apposing Metal Stents With and Without a Double Pigtail Stent in Pancreatic Collections

Pancreatic Collection

Spain
University Hospital, Clermont-Ferrand
University Hospital, Estaing

Completed

Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance (IMPETRAIL)

Healthy Volunteers

France
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inflammation and the Metabolic Syndrome in Humans (LPS)

Metabolic Syndrome X

United States
Janssen Research & Development, LLC

Completed

Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants

Healthy

United Kingdom
University of California, Los Angeles
Medical University of South Carolina; Massachusetts General Hospital

Recruiting

Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder

United States
Baylor College of Medicine
M.D. Anderson Cancer Center; Massachusetts General Hospital

Recruiting

Imaging-Guided Low Intensity Focused Ultrasound (LIFU) (LIFU)

Obsessive-Compulsive Disorder

United States
University of California, Los Angeles

Recruiting

LIFUP for Treatment of Motor Deficits in Parkinson's Disease (LIFUP)

Parkinson Disease

United States
Saol Therapeutics Inc

Active, not recruiting

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain (COMPASS)

Osteoarthritis, Knee Pain

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Completed

ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy (ALPHA)

Pulmonary Arterial Hypertension (PAH)

United States
Casa Colina Hospital and Centers for Healthcare
UCLA Department of Psychology; Tiny Blue Dot INC.

Completed

The Use of LIFUP in Chronic Disorders of Consciousness

Traumatic Brain Injury | Disorder of Consciousness | CVA (Cerebrovascular Accident) | Minimally Conscious State | Vegetative State | Thalamic Infarction | Coma; Prolonged | Minimally Conscious State Plus | Minimally Conscious State Minus | Anoxia, Brain

United States
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
ImmunOs Therapeutics AG
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Solid Tumor, Adult

Australia
University of Puerto Rico

Not yet recruiting

Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas

Aging | Disability Physical

Puerto Rico
Ohio State University Comprehensive Cancer Center

Recruiting

Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth

E-cigarette Use

United States
Theratocular Biotek Co.

Recruiting

A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Thailand
PlaqueTec Ltd
Royal Papworth Hospital

Recruiting

Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease (BIOPATTERN)

Coronary Artery Disease

United Kingdom

Search clinical trials for: LAS 41002

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations